tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Financial Statements

Compare
122 Followers

Dermata Therapeutics Financial Overview

Dermata Therapeutics's market cap is currently $7.33M. The company's EPS TTM is $-14.532; its P/E ratio is ―; Dermata Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -322.00
Operating Income$ -12.51B$ -8.04M$ -9.67M$ -7.86M$ -3.17M
EBITDA$ -12.51B$ 247.22K$ 0.00$ -7.86M$ -3.17M
Net Income$ -12.29B$ -7.79M$ -9.61M$ -7.95M$ -3.43M
Balance Sheet
Cash & Short-Term Investments$ 3.16B$ 7.44M$ 6.24M$ 10.80M$ 530.40K
Total Assets$ 3.53B$ 7.98M$ 6.94M$ 11.62M$ 605.45K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 3.55M
Net Debt$ -3.16B$ -7.44M$ -6.24M$ -10.80M$ 3.02M
Total Liabilities$ 1.97B$ 1.62M$ 922.63K$ 1.52M$ 3.78M
Stockholders' Equity$ 1.56B$ 6.36M$ 6.02M$ 10.11M$ -28.08M
Cash Flow
Free Cash Flow$ -11.16B$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Operating Cash Flow$ -11.16B$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 6.89B$ 7.61M$ 4.28M$ 15.96M$ 2.57M
Currency in USD

Dermata Therapeutics Earnings and Revenue History

Dermata Therapeutics Debt to Assets

Dermata Therapeutics Cash Flow

Dermata Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis